Prot #BTCRC-GI15-015: A Phase II Study of FOLFOX combined with Nab-Paclitaxel (FOLFOX-A) in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

Project: Research project

Project Details

StatusFinished
Effective start/end date9/20/17 → 9/20/23

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #BTCRC-GI15-015)
  • Celgene Corporation (Prot #BTCRC-GI15-015)